Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel solvent-free synthesis of anticancer intermediate CN102911177A. High yield, green chemistry, scalable for API manufacturing.
Patent CN102633625B reveals green ionic liquid method for high-purity fluorocinnamic acid. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN114539342B reveals an industrial method for TUDCA using alcohol solvents to reduce impurities, offering cost-effective pharma intermediate manufacturing.
Novel sulfuryl fluoride fluorination method for phosphonic acids ensuring high yield and mild conditions. Reliable supplier for pharmaceutical intermediates seeking cost reduction.
Patent CN1367773A reveals a novel inorganic base process for Naproxen nitroxyalkylesters, ensuring >98% ee and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN104447452B enables air-stable Suzuki coupling for mercapto compounds. Delivers high-purity intermediates with reduced lead time and scalable manufacturing for global supply chains.
Patent CN116145158B reveals green electrochemical synthesis for NMSBA. Enhances supply chain reliability and reduces waste for agrochemical intermediate manufacturing.
Novel electrochemical debromination patent ensures high purity o-chlorobenzoic acid. Reduces waste and cost for pharmaceutical intermediate manufacturing supply chains.
Patent CN101857613A reveals a novel PTC synthesis for anti-influenza rupestonic acid esters, offering cost reduction in API manufacturing and scalable production.
Patent CN102161978B reveals a green Rhodococcus strain for Cilastatin intermediates. Achieve high optical purity with reduced environmental impact and lower manufacturing costs.
Patent CN103224481A details a high-yield Dehydroequol process using Daidzein. This method offers significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN119019478B reveals novel glycosylation method for Type II Lipoteichoic Acid. Enables scalable production and cost reduction for pharmaceutical intermediates.
Patent CN119019478A reveals a novel glycosylation method for Type II lipoteichoic acid, offering high conversion and scalable manufacturing for immunological research.
Patent CN104926831A reveals a safer Telaprevir intermediate synthesis. Eliminate toxic reagents for cost-effective, high-purity pharmaceutical manufacturing.
Patent CN109796353B reveals a novel two-step route for 5-ALA HCl, offering safer processing and cost reduction in API manufacturing for photodynamic therapy.
Patent CN105481703A enables high-purity S-2-aminobutanol via catalytic hydrogenation. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114790149A reveals a cost-effective route for 2-chloro-4-fluorobenzoic acid, eliminating precious metals for reliable agrochemical intermediate supply.
Patent CN100506789C reveals high-yield sulfonation method. Enhances supply chain reliability and reduces manufacturing costs for global buyers.
Advanced preparation method for S-1-(4-ethoxybenzyl)-3-azapentane-1,5-diamine trihydrochloride. Safe, high-yield route for MRI contrast agent intermediates ensuring cost reduction and supply stability.
Patent CN104480181A reveals enzymatic D-7-ACA synthesis offering high purity and yield. This process enables cost reduction in pharmaceutical intermediates manufacturing and supply chain stability.